Risk algorithms that include pathology adjustment for HER2 amplification need to make further downward adjustments in likelihood scores.
Name:
risk algorithms.pdf
Size:
404.7Kb
Format:
PDF
Description:
Full text, Open Access Article
Affiliation
Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester Academic Health Sciences Centre (MAHSC), Institute of Human Development, University of Manchester, Manchester, M13 9WLIssue Date
2016-10-31
Metadata
Show full item recordAbstract
To assess the need for adjustment in the likelihood of germline BRCA1/2 mutations in women with HER2+ breast cancers. We analysed primary mutation screens on women with breast cancer with unequivocal HER2 overexpression and assessed the likelihood of BRCA1/BRCA2 mutations by age, oestrogen receptor status and Manchester score. Of 1111 primary BRCA screens with confirmed HER2 status only 4/161 (2.5%) of women with HER2 amplification had a BRCA1 mutation identified and 5/161 (3.1%) a BRCA2 mutation. The pathology adjusted Manchester score between 10 and 19% and 20%+ thresholds resulted in a detection rate of only 6.5 and 15% respectively. BOADICEA examples appeared to make even less downward adjustment. There is a very low detection rate of BRCA1 and BRCA2 mutations in women with HER2 amplified breast cancers. The Manchester score and BOADICEA do not make sufficient downward adjustment for HER2 amplification. For unaffected women, assessment of breast cancer risk and BRCA1/2 probability should take into account the pathology of the most relevant close relative. Unaffected women undergoing mutation testing for BRCA1/2 should be advised that there is limited reassurance from a negative test result if their close relative had a HER2+ breast cancer.Citation
Risk algorithms that include pathology adjustment for HER2 amplification need to make further downward adjustments in likelihood scores. 2016, Fam CancerJournal
Familial CancerDOI
10.1007/s10689-016-9942-0PubMed ID
27796713Type
ArticleLanguage
enISSN
1573-7292ae974a485f413a2113503eed53cd6c53
10.1007/s10689-016-9942-0